Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
March 28, 2024	8-K	Report of unscheduled material events or corporate event	0001517022-24-000031.pdf 0001517022-24-000031.rtf 0001517022-24-000031.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 15, 2024	8-K	Report of unscheduled material events or corporate event	0001193125-24-069123.pdf 0001193125-24-069123.rtf 0001193125-24-069123.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 14, 2024	8-K	Report of unscheduled material events or corporate event	0001517022-24-000029.pdf 0001517022-24-000029.rtf 0001517022-24-000029.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 14, 2024	10-K	Annual report which provides a comprehensive overview of the company for the past year	0001628280-24-011270.pdf 0001628280-24-011270.rtf 0001628280-24-011270.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
March 1, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-002022.pdf 0001562180-24-002022.rtf 0001562180-24-002022.xls View HTML
March 1, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-002020.pdf 0001562180-24-002020.rtf 0001562180-24-002020.xls View HTML
March 1, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-002021.pdf 0001562180-24-002021.rtf 0001562180-24-002021.xls View HTML
March 1, 2024	4	Statement of changes in beneficial ownership of securities	0001562180-24-002023.pdf 0001562180-24-002023.rtf 0001562180-24-002023.xls View HTML
February 29, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	0001517022-24-000025.pdf 0001517022-24-000025.rtf View HTML
February 29, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	0001517022-24-000024.pdf 0001517022-24-000024.rtf View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax